{"title":"用于评估尼泊尔公共卫生设施药品管理的监督绩效评估和认可(SPARS)指标的评级间可靠性和有效性。","authors":"Santusta Adhikari, Anup Bastola, Reekesh Shrestha, Narendra Kumar Khanal, Birna Trap","doi":"10.1080/20523211.2025.2477098","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nepal's Ministry of Health and Population piloted the Supervision, Performance Assessment, and Recognition Strategy (SPARS), a multipronged strategy to improve medicines management practices in health facilities. Medicines management supervisors (MMS) periodically assess facility performance using 25 indicators grouped into 5 domains - prescribing, dispensing, ordering and reporting quality and stock and storage management - and provide targeted on-the-job coaching. This study aimed to determine inter-rater reliability (IRR) and validity for SPARS indicators in Nepali context.</p><p><strong>Methods: </strong>We assessed IRR and validity scores with three rater teams assessing medicines management in six public health posts. Each team of three MMS and one technical advisor evaluated two facilities, resulting in 24 total assessments. We calculated the mean and median validity and IRR scores for SPARS overall, and by domain and indicator. Acceptable scores were mean validity and IRR scores ≥75%, moderately acceptable were 50-75%, and unacceptable were <50%.</p><p><strong>Results: </strong>The mean overall IRR (60%) and validity (74%) of all 25 SPARS indicators were significantly different (<i>p</i> < 0.003) but not by domain. Three domains related to dispensing, ordering and reporting, and storage had acceptable mean validity scores, while the prescribing quality domain had an unacceptable mean IRR score. We found significant difference (<i>p</i> < 0.0001) between the indicator IRR and validity acceptability scores. Four (16%) and 12 (48%) of the SPARS indicators had acceptable reproducibility and validity, respectively; 8 (33%) IRR scores and 1 (4%) validity score were unacceptable. Simple indicators (67%) had significantly (<i>p</i> < 0.02) higher reproducibility compared to complex indicators (42%), and higher validity of 80% and 72%, respectively, which was not significant.</p><p><strong>Conclusions: </strong>This study demonstrated that the SPARS indicators produce moderately accurate findings. Validity was significantly higher than IRR and both need improvement, especially for complex indicators. As such, future SPARS implementation should endeavour to include validity and IRR assessments to help improve the indicators.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"18 1","pages":"2477098"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934177/pdf/","citationCount":"0","resultStr":"{\"title\":\"Inter-rater reliability and validity of supervision performance assessment and recognition (SPARS) indicators to assess medicines management in public health facilities in Nepal.\",\"authors\":\"Santusta Adhikari, Anup Bastola, Reekesh Shrestha, Narendra Kumar Khanal, Birna Trap\",\"doi\":\"10.1080/20523211.2025.2477098\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nepal's Ministry of Health and Population piloted the Supervision, Performance Assessment, and Recognition Strategy (SPARS), a multipronged strategy to improve medicines management practices in health facilities. Medicines management supervisors (MMS) periodically assess facility performance using 25 indicators grouped into 5 domains - prescribing, dispensing, ordering and reporting quality and stock and storage management - and provide targeted on-the-job coaching. This study aimed to determine inter-rater reliability (IRR) and validity for SPARS indicators in Nepali context.</p><p><strong>Methods: </strong>We assessed IRR and validity scores with three rater teams assessing medicines management in six public health posts. Each team of three MMS and one technical advisor evaluated two facilities, resulting in 24 total assessments. We calculated the mean and median validity and IRR scores for SPARS overall, and by domain and indicator. Acceptable scores were mean validity and IRR scores ≥75%, moderately acceptable were 50-75%, and unacceptable were <50%.</p><p><strong>Results: </strong>The mean overall IRR (60%) and validity (74%) of all 25 SPARS indicators were significantly different (<i>p</i> < 0.003) but not by domain. Three domains related to dispensing, ordering and reporting, and storage had acceptable mean validity scores, while the prescribing quality domain had an unacceptable mean IRR score. We found significant difference (<i>p</i> < 0.0001) between the indicator IRR and validity acceptability scores. Four (16%) and 12 (48%) of the SPARS indicators had acceptable reproducibility and validity, respectively; 8 (33%) IRR scores and 1 (4%) validity score were unacceptable. Simple indicators (67%) had significantly (<i>p</i> < 0.02) higher reproducibility compared to complex indicators (42%), and higher validity of 80% and 72%, respectively, which was not significant.</p><p><strong>Conclusions: </strong>This study demonstrated that the SPARS indicators produce moderately accurate findings. Validity was significantly higher than IRR and both need improvement, especially for complex indicators. As such, future SPARS implementation should endeavour to include validity and IRR assessments to help improve the indicators.</p>\",\"PeriodicalId\":16740,\"journal\":{\"name\":\"Journal of Pharmaceutical Policy and Practice\",\"volume\":\"18 1\",\"pages\":\"2477098\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934177/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Policy and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/20523211.2025.2477098\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2025.2477098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
背景:尼泊尔卫生和人口部试行了监督、绩效评估和认可战略(SPARS),这是一项多管齐下的战略,旨在改善卫生设施的药品管理做法。药品管理监督员(MMS)使用分为5个领域(处方、调剂、订购和报告质量以及库存和储存管理)的25个指标定期评估设施绩效,并提供有针对性的在职指导。本研究旨在确定SPARS指标在尼泊尔情境下的信度和效度。方法:采用三个评价组对6个公共卫生站的药品管理进行IRR和效度评分。每个小组由三名MMS和一名技术顾问组成,对两个设施进行了评估,总共进行了24次评估。我们计算了SPARS总体的平均和中位数效度和IRR分数,并按域和指标计算。可接受评分为平均效度和IRR评分≥75%,中等可接受评分为50-75%,不可接受评分为:结果:25项SPARS指标的平均总IRR(60%)和效度(74%)存在显著差异(p p p)。效度显著高于IRR,两者都有待改进,尤其是复杂指标。因此,未来的战略资源方案执行应努力包括有效性和内部收益率评估,以帮助改进指标。
Inter-rater reliability and validity of supervision performance assessment and recognition (SPARS) indicators to assess medicines management in public health facilities in Nepal.
Background: Nepal's Ministry of Health and Population piloted the Supervision, Performance Assessment, and Recognition Strategy (SPARS), a multipronged strategy to improve medicines management practices in health facilities. Medicines management supervisors (MMS) periodically assess facility performance using 25 indicators grouped into 5 domains - prescribing, dispensing, ordering and reporting quality and stock and storage management - and provide targeted on-the-job coaching. This study aimed to determine inter-rater reliability (IRR) and validity for SPARS indicators in Nepali context.
Methods: We assessed IRR and validity scores with three rater teams assessing medicines management in six public health posts. Each team of three MMS and one technical advisor evaluated two facilities, resulting in 24 total assessments. We calculated the mean and median validity and IRR scores for SPARS overall, and by domain and indicator. Acceptable scores were mean validity and IRR scores ≥75%, moderately acceptable were 50-75%, and unacceptable were <50%.
Results: The mean overall IRR (60%) and validity (74%) of all 25 SPARS indicators were significantly different (p < 0.003) but not by domain. Three domains related to dispensing, ordering and reporting, and storage had acceptable mean validity scores, while the prescribing quality domain had an unacceptable mean IRR score. We found significant difference (p < 0.0001) between the indicator IRR and validity acceptability scores. Four (16%) and 12 (48%) of the SPARS indicators had acceptable reproducibility and validity, respectively; 8 (33%) IRR scores and 1 (4%) validity score were unacceptable. Simple indicators (67%) had significantly (p < 0.02) higher reproducibility compared to complex indicators (42%), and higher validity of 80% and 72%, respectively, which was not significant.
Conclusions: This study demonstrated that the SPARS indicators produce moderately accurate findings. Validity was significantly higher than IRR and both need improvement, especially for complex indicators. As such, future SPARS implementation should endeavour to include validity and IRR assessments to help improve the indicators.